Day 1 - October 10
Day 2 - October 11
08:00 - 09:00 AM
Registration
REGISTRATION / WELCOME TEA
09:00 - 09:30 AM
Opening
· Prayer by Chaplain
· Welcome remarks: Director, CMC / Director, inStem / Principal, CMC
· Remarks by Secretary, Department of Biotechnology
· Closing remarks: Head, CSCR
Hall A
SESSION: ORGANOIDS AND DISEASE MODELLING
09:30 - 10:00 AM
Maneesha S. Inamdar
Stem Cell Science and Regenerative Medicine (inStem) Bangalore, India
TBC
10:00 - 10:30 AM
Ruchi Tandon
Translational Health Science and Technology Institute (THSTI), Faridabad, India
Harnessing the potential of human liver organoid developed from cells isolated from healthy individuals and patients to develop therapeutics and precision medicines against non-alcoholic fatty liver disease.
10:30 - 11:00 AM
Indumathi Mariappan
L V Prasad Eye Institute (LVPEI), Hyderabad, India
Stem cell derived organoid models to study eye diseases and to validate newer drugs
11:00 - 11:30 AM
Arvind Ramanathan
Institute for Stem Cell Science and Regenerative Medicine (inStem), Bangalore, India
TBC
11:30 AM - 12:30 PM
Break
LUNCH BREAK
Hall A
SESSION: MOLECULAR GENETICS OF INHERITED DISEASES
12:30 - 01:00 PM
Sumita Danda
Christian Medical College Vellore, India
01:00 - 01:30 PM
Sridhar Sivasubbu
Vishwanath Cancer Care Foundation, India
01:30 - 02:30 PM
Aaron Chapla
Christian Medical College Vellore, India
02:30 - 03:00 PM
Ashwin Dalal
Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad, India
Mission program in pediatric rare genetic disorders
Hall B
SESSION: MESENCHYMAL STEM CELLS (MSCs) AND THEIR SECRETOME
12:30 - 01:00 PM
Jyothi Prasanna S
Manipal Institute of Regenerative Medicine, Bengaluru, India
01:00 - 01:30 PM
Ilyas Khan
Swansea University, Wales, United Kingdom
01:30 - 02:00 PM
Yogeswaran Lokanathan
Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
Potential of Wharton's Jelly Mesenchymal Stem Cell-Derived Small Extracellular Vesicles in Managing Metabolic Syndrome in an Animal Model
02:00 - 02:30 PM
Poster presentation and Industry Exhibition
03:00 - 03:30 PM
Break
Hall A
SESSION: POPULATION SCREENING & MANAGEMENT OF GENETIC DISORDERS
03:30 - 04:00 PM
Giriraj Chandak
Centre for Cellular and Molecular Biology Hyderabad, India
Sickle Cell Anaemia: Kal, Aaj, aur Kal (Past, Present and Future)
04:00 - 04:30 PM
Sukesh C Nair
Christian Medical College Vellore, India
04:30 - 05:00 PM
Rekha Pai
Christian Medical College Vellore, India
05:00 - 05:30 PM
Vinod Scaria
Karkinos Healthcare Private Limited, Bengaluru, India
Hall B
SESSION: CELL AND GENE THERAPY
02:30 - 03:00 PM
Vikram Mathews
Christian Medical College Vellore, India
03:00 - 03:30 PM
Shaji RV
Centre For Stem Cell Research, Christian Medical College Vellore, India
03:30 - 04:00 PM
Balamurugan N Appakalai
University of Louisville, USA
Islet cell transplant in general or anything specific or GMP for islet cell process
Hall B
SESSION: MANUFACTURING AND REGULATORY ASPECTS IN CELL AND GENE THERAPY
04:30 - 05:00 PM
Jonathan Yen
St. Jude Children's Research Hospital, Memphis, TN
TBC
05:00 - 05:30 PM
Bruce L. Levine
University of Pennsylvania, Philadelphia, PA
What No T Cell Has Treated Before: Advances in CAR Design and Delivery to Patients
05:30 - 06:00 PM
Priyadarshini Chatterjee
Aurigene Oncology Ltd., Bangalore
Robust Manufacturing of NK cells towards development of Allogeneic Therapies
KEYNOTE ADDRESS
06:00 - 06:40 PM
Keynote
Gene Therapy for Hemoglobinopathies: Recent Developments and Ongoing Challenges
Mitchell Weiss
St. Jude Children's Research Hospital, Memphis, USA
06:40 PM
Conclusion
END OF DAY 1
Hall A
SESSION: CELL THERAPY FOR HEMATOLOGICAL MALIGNANCY
09:00 - 09:30 AM
Biju George
Christian Medical College Vellore, India
TBC
09:30 - 10:00 AM
Aby Abraham
Christian Medical College Vellore, India
TBC
10:00 - 10:30 AM
Mohankumar K M.
Centre For Stem Cell Research, Christian Medical College Vellore, India
TBC
10:00 - 10:30 AM
Thiyagaraj M
Centre For Stem Cell Research, Christian Medical College Vellore, India
Gene-Edited Allogeneic CAR-T Cells for B-Cell Malignancies
10:30 - 11:00 AM
Break
Hall A
SESSION: MICROBIAL INFECTIONS CHALLENGES WAY FORWARD
11:00 - 11:30 AM
Balaji Veeraraghavan
Christian Medical College Vellore, India
11:30 - 12:00 PM
Sitara Swarna Rao Ajjampur
Christian Medical College Vellore, India
12:00 - 12:30 PM
Joy Sarojini Michael
Christian Medical College Vellore, India
12:30 - 01:00 PM
Ajit Chande
Indian Institute of Science Education and Research, Bhopal, India
From HIV Biology to lentiviral vectors: Insights into the mechanisms of antiviral actions
Hall B
SESSION: SCIENTIFIC PROGRESS FROM PHARMA
12:30 - 01:00 PM
Jitendra Vyas
Micro Crispr Pvt. Ltd., Vapi, Gujarat, India
01:00 - 01:30 PM
Tanveer Ahmad
Jamia Milia Islamia, New Delhi, India
AI-Guided and Metabolically Reprogrammed CAR T Cells for Durable Anti-Tumor Immunity
01:30 - 02:00 PM
Pawan K Gupta
Stempeutics Research, Bangalore, India
MSCs in the clinic – current status & future prospects
01:00 - 01:30 PM
Break
LUNCH BREAK
Hall A
SESSION: TECHNOLOGY ADVANCES
01:30 - 02:00 PM
Praveen K Vemula
Stem Cell Science and Regenerative Medicine (inStem) Bangalore, India
02:00 - 02:30 PM
Sunil Laxman
Stem Cell Science and Regenerative Medicine (inStem) Bangalore, India
02:30 - 03:00 PM
Dasaradhi Palakodeti
Stem Cell Science and Regenerative Medicine (inStem) Bangalore, India
03:00 - 03:30 PM
Dhandapany Perundurai
Stem Cell Science and Regenerative Medicine (inStem) Bangalore, India
Hall B
SESSION: GENE EDITING
02:00 - 02:30 PM
Tan Meng How
Nanyang Technological University, Singapore
02:30 - 03:00 PM
Pradeepa Madapura
Queen Mary University of London, London, UK
Use of precision editing, PROTACs to investigate mechanism of neurodevelopmental disorders
03:00 - 03:30 PM
Manish Jaiswal
Tata Institute of Fundamental Research, Hyderabad, India
03:30 - 04:00 PM
Break
Hall A
SESSION: METABOLIC DISORDERS AND NOVEL THERAPEUTIC STRATEGIES
04:00 - 04:30 PM
Nihal Thomas
Christian Medical College Vellore, India
04:30 - 05:00 PM
Ullas Kothur-Seetharam
Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad, India
05:00 - 05:30 PM
Jayanta Bhattacharyya
Indian Institute of Technology Delhi, New Delhi, India
Boosting anti-cancer vaccine by "FORTY" fying immunity to achieve tumor free survival
Hall B
SESSION: NEW FRONTIER OF CELL THERAPY
04:00 - 04:30 PM
John Maher
King's College, London, UK
CAR T-cell immunotherapy of NKG2D-expressing solid tumours
04:30 - 05:00 PM
Sunil Martin
BRIC-Rajiv Gandhi Centre for Biotechnology, Kerala, India
Configuring Chimeric Antigen Receptors for safety and efficacy
05:00 - 05:30 PM
Akshay Sharma
St. Jude Children's Research Hospital, Memphis, USA
Hall B
SESSION: ADVANCES IN DELIVERY VECTORS
06:00 - 06:30 PM
Sivaprakash K Ramalingam
Indian Institute of Technology, Kanpur, India
TBC
06:30 - 07:00 PM
Saravanabhavan Thangavel
Centre For Stem Cell Research, Christian Medical College Vellore, India
TBC
07:00 - 07:30 PM
Timothy Henrich
University of California San Francisco, San Francisco, CA
TBC
07:30 PM
Conclusion
END OF DAY 2 & SYMPOSIUM CONCLUSION